IDEXX Laboratories Inc (IDXX NASDAQ) stock market data APIs
$705.8836
-2.42(-0.3%)
as of November 7, 2025
Try our APIs with
free plan!
IDEXX Laboratories Inc Financial Data Overview
Price chart is built with
Anychart
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Prev. Close
705.8836
Open
703.4649
High
710.2778
Low
695.5337
52 wk Range
356.14-735
Market Cap
56 571 M
P/E Ratio
56.1816
Shares Outstanding
79 851 K
Revenue
4 167 M
EPS
3.4
Beta
1.687
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with IDEXX Laboratories Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get IDEXX Laboratories Inc data using free add-ons & libraries
Get IDEXX Laboratories Inc Fundamental Data
IDEXX Laboratories Inc Fundamental data includes:
- Net Revenue: 4 167 M
- EBITDA: 1 437 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-03
- EPS/Forecast: 3.15
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
IDEXX Laboratories Inc News
New
Notable healthcare headlines for the week: Pfizer, Novo Nordisk, Moderna in focus
Wall Street major averages posted weekly loses amid an AI-tech trade that continued to struggle, with lower consumer sentiment, and the ongoing U.S. government shutdown. Week to date, the Nasdaq and ...
Why IDEXX Laboratories (IDXX) Is Up 13.6% After Strong Q3 Results and Raised 2025 Guidance
IDEXX Laboratories recently reported strong third-quarter results, with revenue of US$1,105.24 million and net income of US$274.61 million, as well as raising its full-year 2025 revenue and EPS guidan...
Earnings Beat: IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
A week ago, IDEXX Laboratories, Inc. (NASDAQ:IDXX) came out with a strong set of quarterly numbers that could potentially lead to a re-rate of the stock. The company beat expectations with revenues of...
Agree To Buy Idexx Laboratories At $600, Earn 5.3% Annualized Using Options
Investors considering a purchase of Idexx Laboratories, Inc. (Symbol: IDXX) shares, but cautious about paying the going market price of $701.05/share, might benefit from considering selling puts among...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
